Lv3
368 积分 2023-11-02 加入
Non-small-cell lung cancer
1天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
1天前
已完结
Assessing Toripalimab in NSCLC
2个月前
已完结
503LBA LBA Orals: Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)
2个月前
已完结
Synthetic lethality in MTAP-deleted tumors: a promising avenue through targeted disruption of the protein methylation pathway
3个月前
已关闭
A Phase II Trial of JDQ443 in KRAS G12C-Mutated NSCLC with PD-L1 Expression <1% or PD-L1 Expression ≥1% and an STK11 Co-Mutation
4个月前
已关闭
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
4个月前
已完结
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
4个月前
已完结
Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis
4个月前
已完结
Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
4个月前
已完结
皖公网安备34019202002308
